ECSP22067445A - SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL ADMINISTRATION - Google Patents

SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL ADMINISTRATION

Info

Publication number
ECSP22067445A
ECSP22067445A ECSENADI202267445A ECDI202267445A ECSP22067445A EC SP22067445 A ECSP22067445 A EC SP22067445A EC SENADI202267445 A ECSENADI202267445 A EC SENADI202267445A EC DI202267445 A ECDI202267445 A EC DI202267445A EC SP22067445 A ECSP22067445 A EC SP22067445A
Authority
EC
Ecuador
Prior art keywords
vaginal administration
pharmaceutical composition
combination
suitable pharmaceutical
fenticonazole
Prior art date
Application number
ECSENADI202267445A
Other languages
Spanish (es)
Inventor
Demirel Gulay Yelken
Original Assignee
Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi filed Critical Exeltis Ilac Sanayii Ve Ticaret Anonim Sirketi
Publication of ECSP22067445A publication Critical patent/ECSP22067445A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4174—Arylalkylimidazoles, e.g. oxymetazolin, naphazoline, miconazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de una combinación que comprende fenticonazol y un agente antibacteriano en un procedimiento terapéutico en mujeres que tienen afecciones del sistema vulvovaginal donde está indicada dicha combinación de agentes activos. Las composiciones farmacéuticas adecuadas para la administración vaginal de una combinación de fenticonazol con un agente antibacteriano, opcionalmente uno o más analgésicos o anestésicos locales, y excipientes o portadores farmacéuticamente aceptables.Use of a combination comprising fenticonazole and an antibacterial agent in a therapeutic procedure in women having conditions of the vulvovaginal system where said combination of active agents is indicated. Pharmaceutical compositions suitable for vaginal administration of a combination of fenticonazole with an antibacterial agent, optionally one or more analgesics or local anesthetics, and pharmaceutically acceptable excipients or carriers.

ECSENADI202267445A 2020-01-31 2022-08-26 SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL ADMINISTRATION ECSP22067445A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR202001511 2020-01-31

Publications (1)

Publication Number Publication Date
ECSP22067445A true ECSP22067445A (en) 2022-11-30

Family

ID=77079220

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSENADI202267445A ECSP22067445A (en) 2020-01-31 2022-08-26 SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL ADMINISTRATION

Country Status (5)

Country Link
EP (1) EP4096655A4 (en)
BR (1) BR112022015112A2 (en)
EC (1) ECSP22067445A (en)
MX (1) MX2022009303A (en)
WO (1) WO2021154188A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0405406D0 (en) * 2004-03-10 2004-04-21 Edko Pazarlama Tanitim Ltd Sti Anti-vaginitis compositions
US20060137684A1 (en) * 2004-12-01 2006-06-29 Celeste Evans Compositions and methods of treating irritation and kit therefor
CN103690476A (en) * 2014-01-06 2014-04-02 海南海力制药有限公司 Micronized fenticonazole nitrate preparation composition and preparation method thereof
TR201413590A3 (en) * 2014-11-17 2021-06-21 Pharmaceutical composition for use in treatment of vaginal infection comprises active substance or its derivative exhibiting antiprotozoal activity, and local anesthetic agent
WO2016100203A1 (en) * 2014-12-20 2016-06-23 Gregg John Malcolm Hall Antimicrobial drug synthesis and therapeutic compositions
RU2674765C2 (en) * 2016-10-03 2018-12-13 Михаил Лукич Ткаченко Antifungal composition of eutectic type (options)
CN108079098A (en) * 2018-02-28 2018-05-29 翔宇药业股份有限公司 Pharmaceutical preparation of anti-fungal infection and preparation method thereof
CN108210448A (en) * 2018-04-09 2018-06-29 翔宇药业股份有限公司 Fenticonazole nitrate suppository and its application

Also Published As

Publication number Publication date
MX2022009303A (en) 2022-09-19
WO2021154188A1 (en) 2021-08-05
EP4096655A4 (en) 2024-02-28
BR112022015112A2 (en) 2022-09-27
EP4096655A1 (en) 2022-12-07

Similar Documents

Publication Publication Date Title
MX2021004546A (en) Implantable drug delivery compositions and methods of use thereof.
CO2021000174A2 (en) Topical compositions for pain relief
AR032352A1 (en) BIOADHESIVE PHARMACEUTICAL COMPOSITION OF GRADUAL HYDRATION AND ITS USE IN THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE ADMINISTRATION OF TESTOSTERONE AND TERBUTALINE TO A MAMMER THROUGH A MUCOSA SURFACE.
BRPI0512311A (en) use of meloxicam in veterinary medicine for the treatment of painful inflammatory diseases
Alavi et al. Local wound care and topical management of hidradenitis suppurativa
ES2190692B1 (en) PHARMACEUTICAL FORMULATION OF AMOXYCLINE AND POTASSIUM CLAVULANATE.
CO2021017958A2 (en) Broad-spectrum antibacterial pharmaceutical formulations comprising lysozyme and methods of using the same
CY1125075T1 (en) SALVIA HAENKEI EXTRACT AS AN ACTIVE AGENT IN TISSUE RESIPHERALIZATION AND HEALING PROCESSES
CO6220945A2 (en) USE OF A COMPOSITION THAT INCLUDES FORMOTEROL AND DIPROPIANATE OF BECLOMETASONE FOR THE PREVENTION AND / OR TREATMENT OF AN EXAMERATION OF ASTHMA
CL2019002172A1 (en) Therapeutic agent for liver diseases.
EP3716996A1 (en) Wound debridement composition and method for treating wounds
ECSP22067445A (en) SUITABLE PHARMACEUTICAL COMPOSITION FOR VAGINAL ADMINISTRATION
AR075866A1 (en) A DOSE OF AVE5026 FOR THE TREATMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH SEVERE RENAL DETERIORATION. USE. PHARMACEUTICAL COMPOSITION
ES2194618T1 (en) ORALALLY DISINTEGRABLE COMPOSITION THAT MIRTAZAPINE INCLUDES.
BRPI0415651A (en) methods for treating, preventing, modifying and / or administering fibromyalgia, and for reducing or preventing an adverse effect associated with the administration of a second active ingredient in a fibromyalgia patient, and, pharmaceutical composition.
Valadares et al. Genitourinary syndrome of menopause
Brueseke et al. Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin
BR112022018654A2 (en) OLIGOSACCHARIDE FORMULATIONS OF KAPPA OPIOID RECEPTOR AGONISTS
AR010432A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING RICHINOLEIC ACID AND ITS USE FOR ANTI-INFLAMMATORY AND ANALGESIC THERAPY
WO2016063265A2 (en) Topical formulation for treating skin or mucosal infections, preparation method and uses thereof
Chen et al. Percutaneous sclerotherapy of sialoceles after parotidectomy with fibrin glue, OK-432, and bleomycin
CL2012000061A1 (en) Sterile aqueous ophthalmic composition comprising a block copolymer of ethylene oxide butylene oxide (eo-bo) and a galactomannan; and use for the treatment of dry eye.
MD2516C2 (en) Anti-inflammatory, antiseptic and antimycotic medicament in the form of gel
AR122320A1 (en) TOPICAL COMPOSITIONS FOR THE RELIEF OF PAIN
AR067320A1 (en) PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF AN ANTIMICROBIAL AGENT AND AN ANTIOXIDANT AGENT FOR THE TREATMENT OF URINARY INFECTIONS